APA (7th ed.) Citation

Yordanova, A., Hose, D., Neben, K., Witzens-Harig, M., Raab, M., & Goldschmidt, H. (2013). Sorafenib in patients with refractory or recurrent multiple myeloma. Hematological oncology, 31(4), . https://doi.org/10.1002/hon.2043

Chicago Style (17th ed.) Citation

Yordanova, Anna, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Marc-Steffen Raab, and Hartmut Goldschmidt. "Sorafenib in Patients with Refractory or Recurrent Multiple Myeloma." Hematological Oncology 31, no. 4 (2013). https://doi.org/10.1002/hon.2043.

MLA (9th ed.) Citation

Yordanova, Anna, et al. "Sorafenib in Patients with Refractory or Recurrent Multiple Myeloma." Hematological Oncology, vol. 31, no. 4, 2013, https://doi.org/10.1002/hon.2043.